For the Inventor, By the Inventor

Enter inventor name

Cranbury, NJ, United States of America

Kevin Anthony Memoli

This inventor holds 21 USPTO granted patents, primarily in Vasopressin Agonists. Top assignees: American Home Products Corporation, Wyeth. Active years: 1990-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Anthony Memoli. Retrieved from https://idiyas.com/inventor/kevin-anthony-memoli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21

% Patents Active = 57.1

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 78(Granted Patents)

Company Filing History:

12 out of 1,567

American Home Products Corporation

Years Active: 1990-2008

Loading Chart...

Areas of Expertise:

Vasopressin Agonists

Oxytocin Receptor Antagonists

Tricyclic Diazepines

Carboxamides

Tetrahydropyrimidines

HDL-C Elevators

Anti-Atherosclerotic Agents

Furanones

Anti-Ulcer Compounds

Heterocyclic Oxime

Cyclohexylphenyl

Biphenyl

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7465722 - Biphenyl vasopressin agonists (2008-12-16),

2. 7329653 - Cyclohexylphenyl vasopressin agonists (2008-02-12),

3. 7223752 - Biphenyl vasopressin agonists (2007-05-29),

4. 7202239 - Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists (2007-04-10),

5. 7109193 - Tricyclic diazepines tocolytic oxytocin receptor antagonists (2006-09-19),

6. 7064120 - Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists (2006-06-20),

7. 7053083 - Cyclohexylphenyl vasopressin agonists (2006-05-30),

8. 6903091 - Biphenyl vasopressin agonists (2005-06-07),

9. 6900200 - Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists (2005-05-31),

10. 6340687 - Substituted tetrahydro-pyrimidine-2(1H)-thione HDL-C elevators useful as antiatherosclerotic agents (2002-01-22),

11. 6268364 - Substitued tetrahydro-1,3,5-triazin-2[1H]-thiones as anti-atherosclerotic agents (2001-07-31),

12. 6160114 - Substituted tetrahydro-1,3,5-triazin-2[1H]-thiones as (2000-12-12),

13. 5438056 - Heterocyclic oxime carbamates (1995-08-01),

14. 5389673 - 4- or 5-(substituted sulfonyl)methyl-3(2H)-furanones (1995-02-14),

15. 5389672 - 4- or 5-(substituted sulfonyl)methyl-3(2H)-furanones (1995-02-14),

Title: The Innovative Mind of Kevin Anthony Memoli

Introduction:

Kevin Anthony Memoli, a talented inventor hailing from Cranbury, NJ, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents:

Kevin Anthony Memoli holds several patents in the field of robotics and artificial intelligence, including a recent patent for a cutting-edge autonomous drone delivery system.

Career Highlights:

With a background in engineering and a passion for pushing the boundaries of what is possible, Kevin has had a successful career working for top tech companies, where he has led teams in developing cutting-edge technologies.

Collaborations:

Throughout his career, Kevin has collaborated with leading researchers and engineers in the industry, fostering a culture of innovation and creativity that has led to the development of revolutionary products.

Conclusion:

Kevin Anthony Memoli's relentless pursuit of innovation and his dedication to creating technologies that shape the future make him a true pioneer in the field of robotics and artificial intelligence.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…